Notes d’épisode
This week: TB-500, the systemic half of the Wolverine stack — a synthetic fragment of thymosin beta-4, a 43-amino-acid protein found in almost every cell in the human body. Jake and Cynthia unpack the mechanism (G-actin binding, cell migration, angiogenesis, the ILK-Akt survival pathway, anti-inflammatory signaling), the animal research on tendons, ligaments, heart and lung repair, the real evidence gap (encouraging reports, yet to be proven in human trials), the July 2026 FDA advisory ...

